Shanghai Fosun Pharmaceutical

Headquarters: Shanghai, China

Employees: 32,258

CEO: Mr. Yifang Wu

show_chart SSE: 600196 +0.17%

Market Cap

CN¥89.20 Billion

CNY as of Jan. 1, 2023

US$12.93 Billion

history Market Cap History

Shanghai Fosun Pharmaceutical market capitalization over time

Evolution of Shanghai Fosun Pharmaceutical market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Shanghai Fosun Pharmaceutical

Detailed Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. researches, develops, manufactures, trades, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing and Research and Development, Healthcare Service, Medical Devices and Medical Diagnosis, Pharmaceutical Distribution and Retail, and Other business Operations. It offers pharmaceutical products in the areas of metabolic and digestive system; antitumor; anti-infective; central nervous system drugs; cardiovascular system; blood system; vaccines; and APIs and intermediates. The company also provides medical diagnosis and medical device products in the field of in vitro diagnostics, the products involve clinical chemistry, clinical immunity, molecular diagnostics, gene chip technology, clinical microbiology, and other fields of laboratory medicine. In addition, it offers medical services in various hospitals. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China.

Stocks & Indices

Shanghai Fosun Pharmaceutical has the following listings and related stock indices.

Stock: SSE: 600196

Stock: FSX: 08HH

Stock: HKEX: 2196



Building A

No. 1289 Yishan Road Fosun Technology Park

Shanghai, 200233


Phone: 86 21 3398 7000

Fax: 86 21 3398 7020